Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

SHE:300436 Revenue

Fujian Cosunter Pharmaceutical had revenue of 108.58M CNY in the quarter ending September 30, 2026, with 1.50% growth. This brings the company's total for the last twelve months to 429.27M, down -0.40% year-over-year. In the year 2025, Fujian Cosunter Pharmaceutical had annual revenue of 416.37M, down -5.68%. That makes Fujian Cosunter Pharmaceutical the 26,084th largest company in the world by revenue and 4,593rd in China.

• Revenue (ttm): 429.27M
• Revenue Growth: -0.40%
• P/S Ratio: 29.64
• Revenue / Employee: n/a
• Employees: 715
• Market Cap: 12.72B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Direct Selling 291.97M 70.1%
• Government Procurement 90.93M 21.8%
• Distribution 25.87M 6.2%
• Other 7.60M 1.8%

Fiscal year ended Dec 31, 2025 See the full SHE:300436 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	416.37M	-25.08M	-5.68%
Dec 31, 2024	441.46M	18.74M	4.43%
Dec 31, 2023	422.71M	36.95M	9.58%
Dec 31, 2022	385.77M	15.32M	4.14%
Jan 1, 2022	370.44M	1.95M	0.53%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error